Zomig-ZMT

Active Ingredient(s): Zolmitriptan
FDA Approved: * February 13, 2001
Pharm Company: * ASTRAZENECA
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zomig-ZMT Overview

Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches. Zolmitriptan is marketed by AstraZeneca with the brand names Zomig, Zomigon (Argentina, Canada & Greece), AscoTop (Germany) and Zomigoro (France). In 2008, Zomig generated nearly $154 million in sales.[1] AstraZeneca's U.S. patent on Zomig tablets expired on November 14, 2012, and its ...

Read more Zomig-ZMT Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Zolmitriptan

Recent Zomig-ZMT Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Zomig-ZMT: (4 results)

Sorted by National Drug Code

• 0310-0209 Zomig-zmt 2.5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
• 0310-0213 Zomig-zmt 5 mg Disintegrating Tablet by Astrazeneca Pharmaceuticals Lp
• 64896-691 Zomig-zmt 2.5 mg Disintegrating Tablet by Impax Laboratories, Inc.
• 64896-692 Zomig-zmt 5 mg Disintegrating Tablet by Impax Laboratories, Inc.

Other drugs which contain Zolmitriptan or a similar ingredient: (2 results)

• ZOLMITRIPTAN 1 discussion
• ZOMIG Zolmitriptan7 discussions

Related Zomig-ZMT Topics: